Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Dyad granted U.S. patent for oligonucleotides

Aug. 23, 1996

Protein Polymer Technologies and Ethicon sign R&D agreement

Aug. 23, 1996

Microsponge retinol system to be codeveloped by APS and Avon

Aug. 16, 1996

Phytopharm files for U.K. marketing approval of Zemaphyte

Aug. 16, 1996

Psoriasin role in psoriasis pathology under scrutiny

Aug. 16, 1996

FK-506: A safe and effective atopic dermatitis treatment

Aug. 9, 1996

Celley issued patent for physiologic lipid mixture from Australian authorities

Aug. 9, 1996

Johnson & Johnson files patent infringement complaint against Penederm

Aug. 9, 1996

Kaken submits NDA for Fiblast in Japan

Aug. 9, 1996

Isotretinoin effective against acne

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...